Teverelix Evaluated in Advanced Prostate Cancer

Clinical trial NCT04693507 · COMPLETED

Trial details

NCT number: NCT04693507
Sponsor: Antev Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostatic Adenoma

Start date: 2021-03-04
Primary completion: 2022-12-05
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.